You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 金斯瑞生物科技(01548.HK)漲超4% 擬分拆傳奇生物擬赴美上市
格隆匯 05-21 10:48
格隆匯5月21日丨金斯瑞生物科技(01548.HK)漲超4%,報17.3港元,本月累漲約25%,總市值328億港元。傳奇生物此前向美國SEC保密提交了F-1註冊聲明草案,擬赴美上市,最快可能於今年二季度上市。3月31日傳奇簽訂融資協議,向買方發行總計1930萬股A類優先股,對價總額約1.5億美元,美國哈德遜灣資本,強生創投和禮來亞洲基金等國際頭部戰投領投,傳奇生物估值約19.5億美元。國信證券研報稱,考慮公司基因合成業務穩健發展,生物製劑CDMO業務快速發展,傳奇的其它細胞治療在研產品線價值未來也將逐步體現,維持合理估值30-34港元,維持“買入”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account